As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian McMahon has spent decades treating the ...

GlobalData expects the chronic hepatitis B therapeutics market across major markets to climb from $1.5 billion in 2024 to ...

Health news and commentary gathered by MedPage Today staff ...

Crisis pregnancy centers — faux health clinics designed to deter pregnant people from getting abortions — are back at the ...

Obamacare premiums are set to spike when enhanced pandemic-era subsidies expire at the end of the year. Many Congressional ...

In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

The United States Radioimmunoassay Market is projected to climb to US$ 310.82 billion by 2033 from US$ 213.71 billion in 2024 ...

The FDA has approved pirtobrutinib (Jaypirca) treatment for adults with relapsed/refractory chronic lymphocytic leukemia or ...

The CDC's vaccine advisory committee could vote this week to change hepatitis B vaccine recommendations for children. Here's ...

A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap ...

A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...